Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims
Recent studies point to the cannabinoid CB2 receptors (CB2r) and the non-cannabinoid receptor GPR55 as potential key targets involved in the response to stress, anxiety, and depression. Considering the close relationship between neuropsychiatric disorders and suicide, the purpose of this study was to evaluate the potential alterations of CB2r and GPR55 in suicide victims. We analyzed gene and protein expression of both receptors by real-time PCR and western blot, respectively, in the dorsolateral prefrontal cortex (DLPFC) of 18 suicide victims with no clinical psychiatric history or treatment with anxiolytics or antidepressants, and 15 corresponding controls. We used in situ proximity ligation assay to evaluate whether the receptors formed heteromeric complexes and to determine the expression level of these heteromers, also assessing the co-expression of heteromers in neurons, astroglia, or microglia cells. CB2r and GPR55 gene expressions were significantly lower (by 33 and 41%, respectively) in the DLPFC of suicide cases. CB2r protein expression was higher, as were CB2-GPR55 heteroreceptor complexes. The results also revealed the presence of CB2-GPR55 receptor heteromers in both neurons and astrocytes, whereas microglial cells showed no expression. We did not observe any significant alterations of GPR55 protein expression. Additional studies will be necessary to evaluate if these alterations are reproducible in suicide victims diagnosed with different psychiatric disorders. Taken together, the results suggest that CB2r and GPR55 may play a relevant role in the neurobiology of suicide.
KeywordsCB2r GPR55 Suicide Dorsolateral prefrontal cortex Gene expression In situ proximity ligation assay
Compliance with Ethical Standards
Conflicts of Interest
The authors declare that they have no conflicts of interest.
- 8.Zarruk JG, Fernandez-Lopez D, Garcia-Yebenes I et al. Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection. Stroke, 2011;Google Scholar
- 20.Uriguen L, Garcia-Fuster MJ, Callado LF et al. Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment. Psychopharmacology (Berl), 2009; 206(2), 313–324.CrossRefGoogle Scholar
- 27.Garcia-Gutierrez MS, Garcia-Bueno B, Zoppi S, Leza JC, Manzanares J. Chronic blockade of cannabinoid CB(2) receptors induces anxiolytic-like actions associated to alterations in GABA(A) receptors. Br J Pharmacol, 2011;Google Scholar
- 28.Garcia-Gutierrez MS, Perez-Ortiz JM, Gutierrez-Adan A, Manzanares J. Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors. Br J Pharmacol, 160(7), 1773–1784.Google Scholar
- 41.Sylantyev S JT, Ross RA, Rusakov, DA. The enigmatic receptor GPR55 potentiates neurotransmitter release at central synapses. Society for Neuroscience Conf Proc, Washington, 2011; Program 653.01, Poster B28Google Scholar
- 42.Jensen TP SS, Ross RA, Rusakov DA. GPR55 modulates transmitter release and short term plasticity in the hippocampus by initiating store mediated pre-synaptic Ca2+ entry. Soc for Neurosci Conf Proc, Washington, 2011; Program 448.08, Poster G4Google Scholar
- 45.Liu QR, Pan CH, Hishimoto A et al. Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands. Genes Brain Behav, 2009; 8(5), 519–530.CrossRefPubMedPubMedCentralGoogle Scholar
- 46.Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego, Calif, 2001; 25(4), 402–408.Google Scholar
- 55.Campos AC, Moreira FA, Gomes FV, Del Bel EA, Guimaraes FS. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2012; 367(1607), 3364–3378.CrossRefGoogle Scholar
- 61.Soderberg O, Leuchowius KJ, Gullberg M et al. Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay. Methods (San Diego, Calif, 2008; 45(3), 227–232.Google Scholar